NIKA (Nika Pharmaceuticals) Net Margin %: 0.00% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NIKA Nika Pharmaceuticals Inc NIKA
12 GF Score
Price $0.77
! 3 Warning Signs
View Full Analysis

What is Nika Pharmaceuticals Net Margin %?

Nika Pharmaceuticals NIKA 12 Net Margin % is 0.00% as of Mar. 2026. GuruFocus rates NIKA with a GF Score™ of 12/100. The stock has 3 warning signs investors should review. Among 962 Drug Manufacturers companies, Nika Pharmaceuticals ranks worse than 103950% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Nika Pharmaceuticals's Net Income for the three months ended in Mar. 2026 was $-0.01 Mil. Nika Pharmaceuticals's Revenue for the three months ended in Mar. 2026 was $0.00 Mil. Therefore, Nika Pharmaceuticals's net margin for the quarter that ended in Mar. 2026 was 0.00%.

The historical rank and industry rank for Nika Pharmaceuticals's Net Margin % or its related term are showing as below:


NIKA's Net Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 5.56
* Ranked among companies with meaningful Net Margin % only.

Nika Pharmaceuticals  (OTCPK:NIKA) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Nika Pharmaceuticals Net Margin % Related Terms

Nika Pharmaceuticals Net Margin % Historical Data

* Premium members only.

The historical data trend for Nika Pharmaceuticals's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nika Pharmaceuticals Net Margin % Chart

Nika Pharmaceuticals Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Net Margin %
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Nika Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

NIKA vs EOLS, EBS, ELTP: Net Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Nika Pharmaceuticals's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nika Pharmaceuticals Net Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Nika Pharmaceuticals's Net Margin % distribution charts can be found below:

* The bar in red indicates where Nika Pharmaceuticals's Net Margin % falls into.


NIKA
12GF Score
Nika Pharmaceuticals Inc NIKA
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nika Pharmaceuticals Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Nika Pharmaceuticals's Net Margin for the fiscal year that ended in Dec. 2025 is calculated as

Net Margin=Net Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-0.076/0
= %

Nika Pharmaceuticals's Net Margin for the quarter that ended in Mar. 2026 is calculated as

Net Margin=Net Income (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-0.013/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 0.00% mean?
Nika Pharmaceuticals (NIKA) has a Net Margin % of 0.00% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Nika Pharmaceuticals and its competitors. According to the industry distribution chart, Nika Pharmaceuticals ranks #999999 out of 962 companies in the Drug Manufacturers industry.
Is Nika Pharmaceuticals' Net Margin % too high?
Nika Pharmaceuticals' current Net Margin % is 0.00%. Based on the distribution chart, Nika Pharmaceuticals ranks #999999 out of 962 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Nika Pharmaceuticals has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Nika Pharmaceuticals' Net Margin % compare to EOLS and EBS?
According to the Drug Manufacturers industry distribution chart, Nika Pharmaceuticals ranks #999999 out of 962 companies for Net Margin %. This places Nika Pharmaceuticals in the lower half of its industry. The industry median Net Margin % is 5.56. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Drug Manufacturers company?
The median Net Margin % among Drug Manufacturers companies is 5.56, based on 962 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Nika Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median Net Margin % is 5.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nika Pharmaceuticals's current Net Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nika Pharmaceuticals stock overvalued right now?
Nika Pharmaceuticals (NIKA) has a current Net Margin % of 0.00%. The current Net Margin % is 0.00%. Nika Pharmaceuticals' overall GF Score™ is 12/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Nika Pharmaceuticals (NIKA), the current Net Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nika Pharmaceuticals Business Description

Address 2269 Merrimack Valley Avenue, Henderson, NV, USA, 89044
Nika Pharmaceuticals Inc is a company involved in development and distribution of a variety of pharmaceutical products, including dietary supplements and antiviral drugs. It has acquired the exclusive rights for production and distribution of the dietary supplements Physiolong and Carotilen, as well as the drug TNG, which has been clinically tested on AIDS patients.
12GF Score

Get the complete analysis for NIKA

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.77
Price